
Behfar Ehdaie, MD, MPH
Urologic Surgeon
Titles
Associate Attending Surgeon
Clinical Expertise
Prostate Cancer; Kidney Cancer; Minimally Invasive and Robotic-Assisted Techniques; MRI Image-Guided Diagnostic and Therapeutic Procedures
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Ehdaie accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-422-4406 Office Phone
- Speaks English

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Georgetown University School of Medicine; MPH, Harvard University School of Public Health
Residencies
Urology - University of Virginia School of Medicine
Fellowships
Memorial Sloan Kettering Cancer Center
Board Certifications
Urology
I am a surgeon with special expertise in employing techniques that are minimally invasive for the treatment of urologic cancers, focusing on the novel management of prostate cancer, kidney tumors, and bladder cancer.
During my MSK fellowship I received advanced training in focal therapies, which include a variety of noninvasive techniques for destroying small tumors inside the prostate while leaving the gland intact and sparing most of its healthy tissue. I’ve also been involved in pioneering minimally invasive treatments for prostate cancer including robot-assisted procedures.
Read more
In addition, I have advanced skills in MRI-guided procedures for the diagnosis and treatment of prostate cancer and have performed more than 500 MRI-guided prostate biopsies. I’m also one of only a handful of surgeons experienced in doing extensive lymph node removals at the time of prostate surgery.
Committed to achieving cures while preserving quality of life, I am pioneering the development of a novel therapy for prostate cancer for men with less-advanced disease or tumors that are in only one area of the prostate. I’m currently the principal investigator in a clinical trial of a therapy called partial gland ablation that involves using precisely targeted ablative technology to treat only those areas containing prostate cancer cells. Preserving the remaining healthy gland allows physicians to deliver a treatment that is without side effects, such as incontinence or erectile dysfunction.
Dedicated to patient-centered care and eliminating the side effects associated with overtreatment of men with low-risk prostate cancer, I support the idea of active surveillance in men with low-risk disease. I am seeking to develop one of the largest surveillance clinics in the world, which includes both advanced imaging and the use of biomarkers to detect cancer progression.
I am an international expert in prostate cancer, and have done numerous invited presentations to academic medical centers and professional societies in the United States and around the world. In addition, I am a member of guideline committees that determine optimal prostate cancer management and work to improve prostate cancer biopsy outcomes.
I’ve published extensively, with more than 16 peer-reviewed studies. In addition, I serve on the editorial boards or am a reviewer on multiple prestigious journals including European Urology, Frontiers in Genitourinary Oncology, the Annals of Surgical Oncology, Cancer, and the British Journal of Urology International.
I am focused on serving my patients and their families and to offering integrated treatment plans tailored to each patient’s needs, concerns, and values.
Awards and Honors
- Castle Connolly: America's Top Doctors (2023)
- Imperial College London Award – Best Paper in Prostate Cancer (2022)
- Member, American Urological Association Core Curriculum Education Committee
- Clinical Chair, Advanced Practice Pathology Program, College of American Pathologists
- Review of the Year, Journal of Urology (2016)
- Prostate Cancer Foundation Award – First Prize, Society of Urologic Oncology (2013)
- Administrative Chief Fellow, Memorial Sloan Kettering Cancer Center
- Alpha Omega Alpha Honor Society, Georgetown University School of Medicine
- Grants: NIH LRP (principal investigator), NIH RO1 (co-investigator), Department of Defense (co-principal investigator), PCORI (co-investigator)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Ehdaie
- A Study of the NanoKnife System in People with Localized Prostate Cancer

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Ehdaie’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Behfar Ehdaie discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].